259 related articles for article (PubMed ID: 33607853)
1. A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States.
Annan E; Stockbridge EL; Katz D; Mun EY; Miller TL
Medicine (Baltimore); 2021 Feb; 100(7):e24838. PubMed ID: 33607853
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.
Tasillo A; Salomon JA; Trikalinos TA; Horsburgh CR; Marks SM; Linas BP
JAMA Intern Med; 2017 Dec; 177(12):1755-1764. PubMed ID: 29049814
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
[TBL] [Abstract][Full Text] [Related]
4. The Prevalence of Latent Tuberculosis Infection in the United States.
Mancuso JD; Diffenderfer JM; Ghassemieh BJ; Horne DJ; Kao TC
Am J Respir Crit Care Med; 2016 Aug; 194(4):501-9. PubMed ID: 26866439
[TBL] [Abstract][Full Text] [Related]
5. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
[TBL] [Abstract][Full Text] [Related]
6. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
Campbell JR; Krot J; Elwood K; Cook V; Marra F
Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
[TBL] [Abstract][Full Text] [Related]
7. Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
Stockbridge EL; Loethen AD; Annan E; Miller TL
PLoS One; 2020; 15(12):e0243102. PubMed ID: 33270737
[TBL] [Abstract][Full Text] [Related]
8. Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011-2012 National Health and Nutrition Examination Survey.
Yelk Woodruff R; Hill A; Marks S; Navin T; Miramontes R
J Immigr Minor Health; 2021 Aug; 23(4):806-812. PubMed ID: 32761297
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
[TBL] [Abstract][Full Text] [Related]
10. Missed opportunities to prevent tuberculosis in foreign-born persons, Connecticut, 2005-2008.
Guh A; Sosa L; Hadler JL; Lobato MN
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1044-9. PubMed ID: 21740666
[TBL] [Abstract][Full Text] [Related]
11. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
Wilson FA; Miller TL; Stimpson JP
Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
[TBL] [Abstract][Full Text] [Related]
14. Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
Ghassemieh BJ; Attia EF; Koelle DM; Mancuso JD; Narita M; Horne DJ
Am J Respir Crit Care Med; 2016 Aug; 194(4):493-500. PubMed ID: 26890477
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.
Miramontes R; Hill AN; Yelk Woodruff RS; Lambert LA; Navin TR; Castro KG; LoBue PA
PLoS One; 2015; 10(11):e0140881. PubMed ID: 26536035
[TBL] [Abstract][Full Text] [Related]
16. Overseas Treatment of Latent Tuberculosis Infection in US-Bound Immigrants.
Khan A; Phares CR; Phuong HL; Trinh DTK; Phan H; Merrifield C; Le PTH; Lien QTK; Lan SN; Thoa PTK; Thu LTM; Tran T; Tran C; Platt L; Maloney SA; Nhung NV; Nahid P; Oeltmann JE
Emerg Infect Dis; 2022 Mar; 28(3):582-590. PubMed ID: 35195518
[TBL] [Abstract][Full Text] [Related]
17. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
18. US Postarrival Evaluation of Immigrant and Refugee Children with Latent Tuberculosis Infection Diagnosed Overseas, 2007-2019.
Wang Z; Posey DL; Brostrom RJ; Morris SB; Marano N; Phares CR
J Pediatr; 2022 Jun; 245():149-157.e1. PubMed ID: 35120982
[TBL] [Abstract][Full Text] [Related]
19. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
Costa AG; Carvalho BKS; Araújo-Pereira M; Ibiapina HNS; Spener-Gomes R; Souza AB; Gomes-Silva A; Andrade AMS; Silva EC; Arriaga MB; Benjamin A; Rocha MS; Moreira ASR; Oliveira JG; Figueiredo MC; Turner MM; Durovni B; Cavalcante S; Kritski AL; Rolla VC; Sterling TR; Andrade BB; Cordeiro-Santos M;
Microbiol Spectr; 2021 Dec; 9(3):e0116321. PubMed ID: 34851140
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Latent Tuberculosis Infection Among Non-US-Born Persons by Country of Birth-United States, 2012-2017.
Collins JM; Stout JE; Ayers T; Hill AN; Katz DJ; Ho CS; Blumberg HM; Winglee K;
Clin Infect Dis; 2021 Nov; 73(9):e3468-e3475. PubMed ID: 33137172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
